Image of Philipp Martin

Philipp Martin

Associate

Email

philipp.martin@aoshearman.com

Phone

+49 69 2648 5506

Offices

Frankfurt

V-CARD
Philipp advises private equity funds and other financial sponsors on M&A transactions, including advise on acquisitions, disposals, joint ventures, co-investments as well as preferred equity and hybrid investments.
Philipp has a wide range of experience advising sponsors on inbound cross-border investments, mainly in the business services, industrial and financial sectors.

Experience

Representative matters

Brookfield Asset Management on the USD5bn acquisition of Modulaire from TDR Capital. 

APAX Partners on various matters, including the acquisition of WGSN from Ascential. 

The Riverside Company on the majority investment in GFOS group.

Nimbus on the sale of Extrusion Technology Group (ETG) to Gamut Capital Management’s portfolio company Davis-Standard.

Charterhouse Capital Partners on the acquisition of Telio from Deutsche Beteiligungs AG (DBAG).

A consortium comprising of Life Sciences Partners (now EQT Life Sciences), HealthCap and Pureos Bioventures on the carve-out of the satoreotide business from Ipsen Pharma SAS (now Ariceum Therapeutics).

Exponent’s portfolio company Evergreen Garden Care on the acquisition of gpi green partners international GmbH & Co. KG.

Deutsche Beteiligungs AG (DBAG) on the acquisition of Dantherm from Procuritas et al.

FNZ on the USD1.4bn capital raise from CPP Investments and Motive Partners. 

Qualifications

Admissions

Germany, 2021 (Rechtsanwalt)

Academic

Second State Examination, Law, Upper Regional Court Frankfurt, 2021

First State Examination, Law, Goethe University Frankfurt, 2018

Disclaimer
A&O Shearman was formed on May 1, 2024 by the combination of Shearman & Sterling LLP and Allen & Overy LLP and their respective affiliates (the legacy firms). Any matters referred to above may include matters undertaken by one or more of the legacy firms rather than A&O Shearman.